Skip to main content

Table 2 Assessment schedule

From: Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial

  Pre treatment Chemoradiotherapy(CRT) The end of CRT Post treatment
1w 2w 3w 4w 5w 6w 7w 1w 2w 3w 4w
Performance status v v    v    v      v
Photograph v v v v v v v v   v v v v
PRO v v v v v v v v   v v v v
Body weight v      v   v      v
Blood exam v             
Adverse events v v v v v v v v   v v v v
  1. Abbreviation: PRO patient reported outcome, CDDP cisplatin, RT radiotherapy